Clinical Trials Study
Copyright ©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Aug 14, 2014; 20(30): 10585-10590
Published online Aug 14, 2014. doi: 10.3748/wjg.v20.i30.10585
Diagnostic value of controlled attenuation parameter for liver steatosis in patients with chronic hepatitis B
Chun-Yan Wang, Wei Lu, Dong-Sheng Hu, Guang-Dong Wang, Xiao-Jing Cheng
Chun-Yan Wang, Wei Lu, Dong-Sheng Hu, Tianjin Second People’s Hospital, Tianjin 300192, China
Guang-Dong Wang, Rizhao People’s Hospital, Rizhao 276800, Shandong Province, China
Xiao-Jing Cheng, Tianjin Medical University, Tianjin 300070, China
Author contributions: Wang CY performed the research and wrote the paper; Lu W designed the research; Hu DS contributed to the statistical data; Wang GD analyzed the data; Cheng XJ contributed to the case collection.
Supported by China Hepatitis Prevention and Treatment Foundation Wang Baoen Liver Fibrosis Research Fund, No. xjs20110402
Correspondence to: Chun-Yan Wang, Deputy Chief Physician, Tianjin Second People’s Hospital, Tianjin 300192, China. water4645@sina.com
Telephone: +86-22-27468207 Fax: +86-22-27468207
Received: December 23, 2013
Revised: March 3, 2014
Accepted: May 12, 2014
Published online: August 14, 2014
Core Tip

Core tip: In recent years, numerous patients suffer from steatosis combined with hepatitis B virus infection. Hence, the amount of fat in the liver of these patients should be evaluated. This study aimed to investigate the diagnostic importance of controlled attenuation parameter, evaluated by transient elastography, for liver steatosis in patients with chronic hepatitis B.